Kfar Saba, Israel, July 14, 2025 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “company” or “ParaZero”), an aerospace company focused on safety systems for commercial unmanned aerial systems and counter UAS systems, announced the appointment of Mr. Ariel Alon, a seasoned executive to the role of Chief Executive Officer, effective immediately.

Shares of crypto-linked companies popped in early trading Monday as the world's largest Bitcoin continued its surge over the weekend.

Becton Dickinson will spin off its biosciences and diagnostic business and merge it with Waters, and plans to use at least $2 billion of the proceeds to buy back stock.

Randi Weingarten, president at the American Federation of Teachers, joins ‘Squawk Box' to discuss the AFT's partnership with Anthropic, Microsoft, and OpenAI on a new AI initiative, the challenges of AI in education, and more.

U.S. shale producer Occidental Petroleum said on Monday its Gulf of Mexico production in the second quarter was curtailed due to third-party constraints, extended maintenance, and schedule-related delays.

– Institute of Human Genetics at Heidelberg University Hospital ongoing EEG biomarker study on 15q13.3 CNVs – – Collaboration aims to uncover novel insights into the brain's functional architecture in rare genetic conditions – – Building and growing a license business is an increasingly important pillar of Firefly's commercial strategy – KENMORE, N.Y., July 14, 2025 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, is pleased to highlight its ongoing collaboration with Prof.

GUANGZHOU, China, July 14, 2025 (GLOBE NEWSWIRE) -- Viomi Technology Co., Ltd (“Viomi” or the “Company”) (NASDAQ: VIOT), a leading technology company for home water solutions in China, today announced that its board of directors has approved the declaration and distribution of a special dividend (the “Special Dividend”) of US$0.0293 per ordinary share (US$0.0880 per American depositary share, or ADS). The aggregate amount of the Special Dividend will be approximately US$6 million. The Special Dividend is expected to be paid on or around August 18, 2025 to the holders of the Company's ordinary shares, and on or around August 21, …

TORONTO--(BUSINESS WIRE)--Docebo Inc. (Nasdaq:DCBO; TSX:DCBO) ("Docebo" or the "Company"), a leading learning platform provider with a foundation in artificial intelligence (AI) and innovation, announced today that it will hold a conference call to discuss its second quarter fiscal year 2025 results on Friday, August 8, 2025 at 8:00 a.m. (ET). Alessio Artuffo, President and Chief Executive Officer, and Brandon Farber, Chief Financial Officer will host a live question and answer session to discu.

Capricor Therapeutics's dip caused by the Complete Response Letter is a buying opportunity considering the readout of HOPE-3 within 2-3 months. Based on HOPE-2 data and the expected course of Duchenne muscular dystrophy cardiomyopathy, I estimate a very high probability of a positive readout in HOPE-3, at least for cardiac endpoints. CAPR remains well funded through approval, not accounting for milestone payments, future royalty revenue, and a potential Priority Review Voucher worth $150M.

Cash runway extended through 2026, beyond September 30, 2026 sunset date for rare pediatric priority review voucher (PRV) program Additional funding allows Company to advance strategic alternatives for OS Animal Health, close out OST-504 (previously ADXS-504) prostate cancer study and initiate AI-driven next-gen tADC product candidate modeling New York, New York--(Newsfile Corp. - July 14, 2025) - OS Therapies (NYSE American: OSTX) ("OS Therapies" or "the Company"), a clinical-stage immunotherapy and Antibody Drug Conjugate (ADC) biopharmaceutical company, today announced that it has closed its previously announced warrant exercise inducement and exchange offer. The Company raised a total of $4.2 million …

A coalition backed by Google , Stripe and Shopify will spend $1.7 million to buy carbon removal credits from three early stage firms on behalf of the tech giants to help scale up the nascent markets, an executive told Reuters.

Portillo's growth prospects are in the early stages but are favorable given the industry backdrop and strategic approach management is taking. PTLO's new units come with the benefit of scale. Combine scale and initiatives such as the rewards programs; surprise growth is likely. In comparison to other fast-casual competitors, the company remains cheap, trading at near all-time lows, making the risk/reward outlook appealing.

America must control its copper supply — but Washington doesn't have many chances to get it right.

Death and Taxes – the only two guaranteed parts of life. We can help avoid the second one with these picks. You need income, but you don't need to pay excessive taxes on it. The yield is deceptive, and taxes are sneaky.

Proposed transaction creates the broadest, most flexible portfolio of orthopedic robotics and navigation technologies to meet surgeons' needs Acquisition expected to be neutral to adjusted earnings per share in 2025 – 2027 and accretive thereafter and to contribute to revenue growth beginning in 2027 WARSAW, Indiana and AUSTIN, Texas, July 14, 2025 (GLOBE NEWSWIRE) -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, and Monogram Technologies Inc. (NASDAQ: MGRM), an orthopedic robotics company, today announced they have entered into a definitive agreement for Zimmer Biomet to acquire all outstanding shares of stock of Monogram for …

The companies were awaiting clearance from China's State Administration for Market Regulation.

Emily Field, head of European pharma research at Barclays, discusses which drug makers would be most impacted by 30% U.S. tariffs on EU imports, and the likelihood President Trump moves ahead with up to 200% tariffs on foreign pharma products.

Toronto, Ontario--(Newsfile Corp. - July 14, 2025) - Seabridge Gold Inc. (TSX: SEA) (NYSE: SA) ("Seabridge" or the "Company") announced today that Tudor Gold Corp. ("Tudor") has filed a Notice of Appeal in the British Columbia Supreme Court against the Chief Gold Commissioner of British Columbia (the "CGC") and Seabridge which appeals a decision of the CGC rejecting an application brought by Tudor that seeks, in effect, to rescind the legal mechanism which prioritizes Seabridge's rights to use land passing through Tudor's claims for the KSM Project's Mitchell Treaty Tunnels ("MTT"). Tudor previously had applied for a decision from the …

The Special Meeting of Shareholders to approve the Business Combination with Mount Logan Capital to be Held on August 22, 2025, with a record date for the meeting of July 8, 2025 The Special Meeting of Shareholders to approve the Business Combination with Mount Logan Capital to be Held on August 22, 2025, with a record date for the meeting of July 8, 2025

I'm zooming in on four core holdings, about a third of my portfolio, to explain why I'm betting big and staying patient through short-term noise. These stocks offer a mix of secular and cyclical growth, pricing power, and rising moats. They aren't high yielders, but I believe they'll outperform. My concentrated portfolio is volatile by design, but I'm in it for long-term alpha. I see dip-buying opportunities in some and strong hold cases in others.